摘要:
By using FPRL1 ligand, which comprises the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 17 or SEQ ID NO: 21, and FPRL1, an efficient screening for FPRL1 agonist or FPRL1 antagonist can be performed.
摘要翻译:通过使用包含与SEQ ID NO:1,SEQ ID NO:17或SEQ ID NO:21表示的氨基酸序列相同或基本上相同的氨基酸序列的FPRL1配体和FPRL1,FPRL1激动剂的有效筛选 或FPRL1拮抗剂。
摘要:
By using FPRL1 ligand, which comprises the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, SEQ ID NO: 17 or SEQ ID NO: 21, and FPRL1, an efficient screening for FPRL1 agonist or FPRL1 antagonist can be performed.
摘要翻译:通过使用包含与SEQ ID NO:1,SEQ ID NO:17或SEQ ID NO:21表示的氨基酸序列相同或基本上相同的氨基酸序列的FPRL1配体和FPRL1,FPRL1激动剂的有效筛选 或FPRL1拮抗剂。
摘要:
By using (1) a G protein-coupled receptor protein having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1 or its salt and (2) a fatty acid or an eicosanoid, a compound or its salt that can change the binding properties of the receptor protein or its salt to the fatty acid or the eicosanoid can be screened efficiently.
摘要翻译:通过使用(1)具有与SEQ ID NO:1所示的氨基酸序列相同或基本相同的氨基酸序列的G蛋白偶联受体蛋白质或其盐和(2)脂肪酸或类花生酸,化合物 或者可以有效地筛选能够将受体蛋白质或其盐与脂肪酸或类花生酸形成的结合性质改变的盐。
摘要:
By using (1) a G protein-coupled receptor protein having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1 or its salt and (2) a fatty acid or an eicosanoid, a compound or its salt that can change the binding properties of the receptor protein or its salt to the fatty acid or the eicosanoid can be screened efficiently.
摘要翻译:通过使用(1)具有与SEQ ID NO:1所示的氨基酸序列相同或基本相同的氨基酸序列的G蛋白偶联受体蛋白质或其盐和(2)脂肪酸或类花生酸,化合物 或者可以有效地筛选能够将受体蛋白质或其盐与脂肪酸或类花生酸形成的结合性质改变的盐。
摘要:
The present invention provides a method of screening a compound or its salt that alters binding properties of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, and a ligand capable of specifically binding to the protein or its salt, which comprises using (a) the protein, its partial peptide, or a salt thereof and (b) the ligand; a screening kit therefor, and so on. The screening method and kit of the present invention are useful for screening an agent for the prevention/treatment of, e.g., digestive tract disorders, cancer, immune disorders, type II diabetes mellitus or obesity, etc.
摘要翻译:本发明提供一种筛选化合物或其盐的方法,其改变包含与SEQ ID NO:1所示的氨基酸序列相同或基本上相同的氨基酸序列的蛋白质的结合性,或其盐,和 能够特异性结合蛋白质或其盐的配体,其包括使用(a)蛋白质,其部分肽或其盐和(b)配体; 一个筛选工具,等等。 本发明的筛选方法和试剂盒可用于筛选用于预防/治疗例如消化道疾病,癌症,免疫疾病,II型糖尿病或肥胖症等的药剂。
摘要:
The present invention provides a method of screening a compound or its salt that alters binding properties of a protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, and a ligand capable of specifically binding to the protein or its salt, which comprises using (a) the protein, its partial peptide, or a salt thereof and (b) the ligand; a screening kit therefor, and so on. The screening method and kit of the present invention are useful for screening an agent for the prevention/treatment of, e.g., digestive tract disorders, cancer, immune disorders, type II diabetes mellitus or obesity, etc.
摘要翻译:本发明提供一种筛选化合物或其盐的方法,其改变包含与SEQ ID NO:1所示的氨基酸序列相同或基本上相同的氨基酸序列的蛋白质的结合性,或其盐,和 能够特异性结合蛋白质或其盐的配体,其包括使用(a)蛋白质,其部分肽或其盐和(b)配体; 一个筛选工具,等等。 本发明的筛选方法和试剂盒可用于筛选用于预防/治疗例如消化道疾病,癌症,免疫疾病,II型糖尿病或肥胖症等的药剂。
摘要:
The present invention provides a method of screening an agonist/antagonist of a G protein-coupled receptor protein comprising the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1, or a salt thereof, which comprises using the receptor protein or its salt and a ligand or its salt; and so on. The screening method of the present invention is useful for screening an agent for the prevention/treatment of nervous system diseases or neuropathic pains.
摘要翻译:本发明提供筛选G蛋白偶联受体蛋白激动剂/拮抗剂的方法,其包含与SEQ ID NO:1所示的氨基酸序列相同或基本上相同的氨基酸序列,或其盐,其包含 使用受体蛋白或其盐和配体或其盐; 等等。 本发明的筛选方法可用于筛选用于预防/治疗神经系统疾病或神经性疼痛的药剂。
摘要:
The GPR40 receptor function regulator of the present invention, which comprises a compound having an aromatic ring and a group capable of releasing cation is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
摘要:
By using a G protein-coupled receptor protein containing an amino acid sequence, which is the same or the substantially the same as an amino acid sequence represented by SEQ ID NO:1, SEQ ID NO:10, SEQ ID NO:12 or SEQ ID NO:14, or its salt together with humanin, a compound or its salt capable of changing the binding properties of the above receptor protein or its salt to humanin can be efficiently screened.
摘要翻译:通过使用含有与SEQ ID NO:1,SEQ ID NO:10,SEQ ID NO:12或SEQ ID NO:12表示的氨基酸序列相同或基本相同的氨基酸序列的G蛋白偶联受体蛋白 可以有效地筛选能够改变上述受体蛋白质或其盐对人源的结合特性的化合物或其盐与人源化合物或其盐。
摘要:
By using a G protein-coupled receptor protein containing an amino acid sequence, which is the same or the substantially the same as an amino acid sequence represented by SEQ ID NO:1, SEQ ID NO:10, SEQ ID NO:12 or SEQ ID NO:14, or its salt together with humanin, a compound or its salt capable of changing the binding properties of the above receptor protein or its salt to humanin can be efficiently screened.
摘要翻译:通过使用含有与SEQ ID NO:1,SEQ ID NO:10,SEQ ID NO:12或SEQ ID NO:12表示的氨基酸序列相同或基本相同的氨基酸序列的G蛋白偶联受体蛋白 可以有效地筛选能够改变上述受体蛋白质或其盐对人源的结合特性的化合物或其盐与人源化合物或其盐。